Holger Thurm
Impact in
-
- Lung Cancer Treatments and Mutations
- Brain Metastases and Treatment
- Lung Cancer Diagnosis and Treatment
- Oncology top 2%
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Lung Cancer Treatments and Mutations 37
- Lung Cancer Diagnosis and Treatment 5
- Advanced Breast Cancer Therapies 3
- Oncology 29
- Lung Cancer Research Studies 16
- Colorectal Cancer Treatments and Studies 8
- HER2/EGFR in Cancer Research 4
- Cancer-related Molecular Pathways 3
- Co-authors
- Todd M. Bauer (21 shared papers)Alice T. Shaw (24 shared papers)Benjamin Solomon (27 shared papers)Gerson Peltz (15 shared papers)Enriqueta Felip (19 shared papers)Tony Mok (8 shared papers)Anna Polli (12 shared papers)Geoffrey Liu (6 shared papers)
- Journals
- Journal of Clinical Oncology (13 papers)Annals of Oncology (9 papers)Journal of Thoracic Oncology (6 papers)Cancer Research (4 papers)Lung Cancer (2 papers)
- Partner nations
- United StatesItalyAustralia
In The Last Decade
Holger Thurm
46 papers receiving 2.2k citations
Holger Thurm's Hit Papers
Peers
Comparison fields: 5 of 66
- Pulmonary and Respiratory Medicine 1.6k
- Oncology 1.1k
- Cancer Research 353
- Genetics 163
- Otorhinolaryngology 58
Countries citing papers authored by Holger Thurm
This map shows the geographic impact of Holger Thurm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Holger Thurm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Holger Thurm more than expected).
Fields of papers citing papers by Holger Thurm
This network shows the impact of papers produced by Holger Thurm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Holger Thurm. The network helps show where Holger Thurm may publish in the future.
Co-authors
The 25 scholars most cited alongside Holger Thurm, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | First-Line Lorlatinib or Crizotinib in Advanced ALK -Positive Lung Cancer Hit paper breakdown → | 2020 | 676 |
| 2 | 2019 | 274 | |
| 3 | Lorlatinib in advanced ROS1-positive non-small-cell lung cancer: a multicentre, open-label, single-arm, phase 1–2 trial Hit paper breakdown → | 2019 | 254 |
| 4 | 2009 | 152 | |
| 5 | 2019 | 116 | |
| 6 | 2022 | 86 | |
| 7 | 2020 | 81 | |
| 8 | 2012 | 74 | |
| 9 | 2021 | 70 | |
| 10 | Rare expression of epithelial cell adhesion molecule on residual micrometastatic breast cancer cells after adjuvant chemotherapy. | 2003 | 66 |
| 11 | 2010 | 35 | |
| 12 | 1997 | 31 | |
| 13 | 2020 | 30 | |
| 14 | 2021 | 28 | |
| 15 | 2023 | 28 | |
| 16 | 2017 | 28 | |
| 17 | 2022 | 25 | |
| 18 | 2022 | 24 | |
| 19 | 2020 | 20 | |
| 20 | 2021 | 18 |
About Holger Thurm
Holger Thurm is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Molecular Biology and Epidemiology, having authored 48 papers that have together received 2.3k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (37 papers), Lung Cancer Research Studies (16 papers), Cancer Genomics and Diagnostics (8 papers), Colorectal Cancer Treatments and Studies (8 papers), Lung Cancer Diagnosis and Treatment (5 papers), HER2/EGFR in Cancer Research (4 papers), Advanced Breast Cancer Therapies (3 papers) and Cancer-related Molecular Pathways (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.6k citations), Oncology (1.1k citations), Cancer Research (353 citations), Genetics (163 citations) and Otorhinolaryngology (58 citations). Holger Thurm has collaborated with scholars based in United States, Italy and Australia. Frequent co-authors include Todd M. Bauer, Alice T. Shaw, Benjamin Solomon, Gerson Peltz, Enriqueta Felip, Tony Mok, Anna Polli, Geoffrey Liu, Anna Maria Calella and Julien Mazières. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Journal of Thoracic Oncology, Cancer Research and Lung Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.